Tranexamic acid use for heavy bleeding after cesarean delivery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational, retrospective analysis of cesarean deliveries complicated by primary postpartum hemorrhage at Siriraj Hospital, Mahidol University. Investigators will measure how often tranexamic acid (TXA) has been used over recent years and calculate the growth rate of its use after publication of major guidelines. The study will compare obstetric and perinatal outcomes—such as need for blood transfusion, additional surgical interventions, and neonatal status—between cases that did and did not receive TXA, using hospital records and anesthetic charts. Patients with gestational age <24 weeks, antepartum TXA exposure, missing anesthetic records, or blood loss <1,000 ml are excluded from analysis.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 1\. Patients underwent cesarean delivery with primary postpartum hemorrhage

Exclusion Criteria:

1. Gestational age at less than 24 weeks
2. Absence of the anesthetic record
3. Received tranexamic acid in the antepartum period
4. Blood loss less than 1,000 ml

Where it's running

• Siriraj Hospital
  Bangkoknoi, Bangkok, Thailand Recruiting

Study contacts

• Principal investigator: Patchareya Nivatpumin, M.D. — Siriraj Hospital
• Study coordinator: Patchareya Nivatpumin, M.D.
• Email: patcahreya.niv@mahidol.ac.th
• Phone: +66896662187

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Long-term outcomes after vacuum-induced tamponade for postpartum hemorrhage

  This study will look at women who had postpartum hemorrhage treated with vacuum-induced tamponade at a Zurich hospital to see how they fared over time, including future pregnancies and fertility.

  Recruiting University of Zurich · Zurich, Canton of Zurich · NCT07885072

• Reducing Chronic Pain After Cesarean Delivery

  A single-session pain-relief class called Empowered Relief is tested alongside standard postpartum care to see if it helps women who have ongoing pain after cesarean delivery.

  Recruiting Stanford University · Palo Alto, California · NCT07799883

• Calcium Gluconate After Birth to Reduce Blood Loss in Vaginal Delivery

  This study tests whether giving calcium gluconate right after the baby is born can help reduce blood loss for people having a vaginal delivery.

  Recruiting Rambam Health Care Campus · Haifa · NCT07714902

• Carbetocin Alone vs Carbetocin Plus Oxytocin After Elective Cesarean Delivery

  This study tests whether giving carbetocin by itself after an elective cesarean is just as good as adding a supplemental oxytocin infusion.

  Recruiting Phase 4 Mansoura University · Buraidah, Al-Qassim Region · NCT07636421

• Simulation-based postpartum hemorrhage training to boost anesthesiology team performance

  Senior anesthesiology residents will try a high-fidelity simulation program for postpartum hemorrhage to see if it improves how their teams perform during obstetric emergencies.

  Recruiting Hacettepe University · Ankara, Ankara · NCT07519252

• Carbetocin to prevent heavy bleeding after twin birth

  This trial tests whether a single dose of carbetocin given after the second twin is born reduces heavy bleeding compared with standard oxytocin in people delivering twins.

  Recruiting Phase 4 Sheba Medical Center · Ramat Gan · NCT07401524

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.